European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on August 28, 2026

Aug. 28, 2026

Top 10 Molded Fiber Companies in China 2026: Market Leaders in Eco-Friendly Pulp Molding Solutions

Indeterminate EIN Presswire

Aug. 28, 2026

NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger

Indeterminate GlobeNewswire

Aug. 28, 2026

Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions

Indeterminate GlobeNewswire

Aug. 28, 2026

LiTime Debuts at The smarter E South America 2026 with New Lares Plug-In Home Backup and LiFePO₄ Power Solutions

Indeterminate GlobeNewswire

Aug. 28, 2026

LiTime Estreia no The smarter E South America 2026 com o Novo Lares Plug-In Home Backup e LiFePO₄ Power Solutions

Indeterminate GlobeNewswire

Aug. 28, 2026

Origami Holding Commits $200 Million to New Multifunctional Complex on Ambassadori Island Batumi

Indeterminate GlobeNewswire

Aug. 28, 2026

Critical Metals Corp. Provides Update on Proposed Acquisition of European Lithium

Indeterminate GlobeNewswire

Aug. 28, 2026

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Indeterminate GlobeNewswire

Aug. 28, 2026

FRO – Q2 2026 Presentation

Indeterminate GlobeNewswire

Aug. 28, 2026

Rezolve Ai and Tech Mahindra Forge Global Alliance to Bring Agentic Commerce to Enterprise Scale

Indeterminate GlobeNewswire

Aug. 28, 2026

Walmart Sparky Optimisation: What Brands Should Do to Get Recommended as Sparky Users Spend 40% More

Indeterminate GlobeNewswire

Aug. 28, 2026

Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research

Indeterminate GlobeNewswire

Aug. 28, 2026

XORTX Announces Termination and Postponement of Investor Relations Program

Indeterminate GlobeNewswire

Aug. 28, 2026

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire

Aug. 28, 2026

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Indeterminate GlobeNewswire

Aug. 28, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Aug. 28, 2026

LUX Announces First Anniversary Under Creative Capital Ownership With Exclusive Gianan Wine Collaboration

Indeterminate GlobeNewswire

Aug. 28, 2026

OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

FRO – Second Quarter and Six Months 2026 Results

Indeterminate GlobeNewswire